0001209191-23-058349.txt : 20231212 0001209191-23-058349.hdr.sgml : 20231212 20231212180824 ACCESSION NUMBER: 0001209191-23-058349 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231211 FILED AS OF DATE: 20231212 DATE AS OF CHANGE: 20231212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elam Nevan C CENTRAL INDEX KEY: 0001314773 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32157 FILM NUMBER: 231482384 MAIL ADDRESS: STREET 1: C/O NEKTAR THERAPEUTICS STREET 2: 150 INDUSTRIAL ROAD CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Savara Inc CENTRAL INDEX KEY: 0001160308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841318182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6836 BEE CAVE ROAD STREET 2: BUILDING 3, SUITE 201 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 51285113796 MAIL ADDRESS: STREET 1: 6836 BEE CAVE ROAD STREET 2: BUILDING 3, SUITE 201 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: Mast Therapeutics, Inc. DATE OF NAME CHANGE: 20130312 FORMER COMPANY: FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010928 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-11 0 0001160308 Savara Inc SVRA 0001314773 Elam Nevan C ONE SUMMIT SQUARE, 1717 LANGHORNE NEWTOWN ROAD, SUITE 300 LANGHORNE PA 19047 1 0 0 0 0 Common Stock 2023-12-11 4 M 0 10841 0.82 A 40085 D Stock Option (Right to Buy) 0.82 2023-12-11 4 M 0 10841 0.00 D 2023-12-12 Common Stock 10841 0 D The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 12, 2014. /s/ David Lowrance as attorney-in-fact for Nevan C. Elam 2023-12-12